In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...

At least 2,000 pens labelled as containing tirzepatide and retatrutide were seized along with tens of thousands of empty pens ...

Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

LONDON: Britain’s medicines regulator said on Friday it had made the world’s largest seizure of unlicensed weight-loss medicines, dismantling a factory that made jabs labelled as containing the ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) seized the world's largest cache of unlicensed ...

The EMA is working with social media content creators to try to encourage "safe and responsible" use of weight-loss drugs.

Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price ...

Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, ...

Within six months of its debut, Mounjaro became the second-highest-selling drug in India, recording sales worth Rs 80 crore ...

Shares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.